Clinical trial Recruiting at 1 site Observational Ages 12 Months and up

Improving tests for platelet function disorders

Official title: Towards Improved Diagnostics for Suspected Platelet Function Disorders

Run by Region Stockholm · NCT05985668 · Data updated 2026-11-12

This study is testing new platelet function tests to see if they can help doctors better diagnose and manage bleeding problems in patients with suspected or confirmed platelet function disorders.

Quick facts

Study typeObservational
Ages12 Months and up
SexAll
Enrollment140 (estimated)
SponsorRegion Stockholm
Government
Locations1 site (Stockholm)
StatusRecruiting
StartedSeptember 5, 2023
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 4, 2023
Trial IDNCT05985668 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with known or suspected platelet function disorders who are being evaluated at Karolinska University Hospital.

Probably not a fit

Patients currently on antiplatelet or anticoagulant medications, or those with other coagulation disorders, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the diagnostic accuracy of new platelet function tests in patients with confirmed or suspected platelet function disorders. Participants will be recruited from the Coagulation Unit at Karolinska University Hospital and the Pediatric Coagulation Unit at Astrid Lindgren Children's Hospital. The goal is to enhance the effectiveness of platelet function testing during bleeding investigations, which could lead to better diagnosis and management of these disorders.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses and improved management of patients with platelet function disorders.

How similar studies have gone: While this approach is focused on improving diagnostic accuracy, similar studies have shown promise in enhancing the understanding and management of platelet function disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria, known defects:

* Known platelet function disorder under follow-up at Karolinska University Hospital (genetic or functional assay)
* High likelihood of platelet function disorder (aberrant screening test with inheritance)
* Family investigation for platelet disorder

Exclusion Criteria, known defects::

* Antiplatelet or anticoagulant drugs
* vWF:GPIb below 0.40 IU/mL
* Hematocrit below 0.35 or above 0.50
* Other coagulation disorder

Inclusion Criteria, suspected platelet function disorder:

* Bleeding investigation at Karolinska University Hospital

Exclusion Criteria, suspected platelet function disorder::

* Antiplatelet or anticoagulant drugs
* vWF:GPIb below 0.40 IU/mL
* Hematocrit below 0.35 or above 0.50
* Other coagulation disorder

Where it's running

  • Karolinska University Hospital
    Stockholm, Sweden
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Long-term observation of non-cancer blood disorders

    This study is tracking people with blood disorders like hemophilia and thrombosis for at least 15 years to see how their conditions change over time and gather useful information for doctors and researchers.

    Recruiting at 74 sites American Thrombosis and Hemostasis Network · Phoenix, Arizona and 75 other locations · NCT04398628

  • Group CBT vs. Activity Group for Adults with ADHD

    This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

    Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

  • AI support in emergency medicine helps doctors make differential diagnoses

    This study tests whether a generative AI tool can help emergency doctors arrive at more accurate differential diagnoses for adult patients at Karolinska University Hospital.

    Recruiting Region Stockholm · Stockholm, Huddinge · NCT07766863

  • Predicting prostate cancer response to neoadjuvant darolutamide with a gene biomarker

    This study tests whether a gene-based PCAI ImmunoScore can predict which high-risk localized or locally advanced prostate cancer patients will have minimal residual disease after 90–120 days of darolutamide before surgery.

    Recruiting at 2 sites Phase 2 Region Stockholm · Gothenburg and 1 other locations · NCT07617272

  • Pulse palpation vs arterial blood pressure in circulatory shock

    This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.

    Recruiting Region Stockholm · Stockholm, Stockholm County · NCT07609095

  • Brief Cognitive Behavioral Therapy for Inpatient Psychiatry

    This project tests whether a brief CBT program added to usual inpatient care helps adults with depression or anxiety during their hospital stay.

    Recruiting Region Stockholm · Stockholm · NCT07503951

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.